Literature DB >> 19686366

Review of fractional photothermolysis: treatment indications and efficacy.

Emily P Tierney1, David J Kouba, C William Hanke.   

Abstract

BACKGROUND: Fractional photothermolysis (FP) is one of the most significant milestones in laser technology and resurfacing.
METHODS: Review of the Medline English literature and recent international conferences regarding FP technology, applications, and indications.
RESULTS: Successful conditions treated with nonablative FP reported in the literature include acne scarring; dyschromia and fine wrinkling of photoaging on the face, chest, neck, and hands; melasma; poikiloderma of Civatte; nevus of Ota; scars; minocycline hyperpigmentation; telangiectatic matting; residual hemangioma; granuloma annulare; colloid milium; and disseminated superficial actinic porokeratosis. An advance in 2007 was the introduction of ablative FP (AFP), which results in significantly greater improvement in skin laxity and textural abnormalities. Most recently, AFP has demonstrated significantly greater improvement than nonablative FP in reducing acne scarring and skin redundancy and laxity associated with photoaging.
CONCLUSIONS: Through the induction of microthermal zones of injury, FP technology stimulates a robust and rapid wound healing response resulting in improvement in a diversity of aesthetic, inflammatory, and preneoplastic skin disorders. Further investigation into the technology and diverse array of cutaneous conditions that can benefit from FP is highly needed.

Entities:  

Mesh:

Year:  2009        PMID: 19686366     DOI: 10.1111/j.1524-4725.2009.01258.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  27 in total

1.  Update on fractional laser technology.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

2.  Minocycline toxicity: case files of the University of Massachusetts medical toxicology fellowship.

Authors:  Matthew D Zuckerman; Katherine L Boyle; Christopher D Rosenbaum
Journal:  J Med Toxicol       Date:  2012-09

Review 3.  Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-04-24       Impact factor: 2.744

Review 4.  [Treatment of gunpowder tattoo and foreign bodies after blast injuries].

Authors:  G Weisel; H Pillekamp
Journal:  HNO       Date:  2011-08       Impact factor: 1.284

5.  Novel approach with fractional ultrapulse CO2 laser for the treatment of upper eyelid dermatochalasis and periorbital rejuvenation.

Authors:  Alberto Balzani; Ram M Chilgar; Marzia Nicoli; Stamatis Sapountzis; Davide Lazzeri; Valerio Cervelli; Fabio Nicoli
Journal:  Lasers Med Sci       Date:  2013-01-10       Impact factor: 3.161

Review 6.  Recent Advances in Fractional Laser Resurfacing: New Paradigm in Optimal Parameters and Post-Treatment Wound Care.

Authors:  Francis C Hsiao; Gerald N Bock; Daniel B Eisen
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

7.  White Fibrous Papulosis of the Neck Treated With Fractionated 1550-nm Erbium Glass Laser: A Case Report.

Authors:  Suparuj Lueangarun; Ratchathorn Panchaprateep
Journal:  J Lasers Med Sci       Date:  2016-10-27

8.  Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne.

Authors:  Rui Yin; Lin Lin; Yan Xiao; Fei Hao; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2014-01-06       Impact factor: 4.025

9.  Ablative Fractional 10 600 nm Carbon Dioxide Laser Versus Non-ablative Fractional 1540 nm Erbium-Glass Laser in Egyptian Post-acne Scar patients.

Authors:  Mohamed L Elsaie; Shady M Ibrahim; Wael Saudi
Journal:  J Lasers Med Sci       Date:  2017-12-26

10.  Fractional Erbium laser in the treatment of photoaging: randomized comparative, clinical and histopathological study of ablative (2940nm) vs. non-ablative (1540nm) methods after 3 months.

Authors:  Juliano Borges; Tullia Cuzzi; Carlos Alberto Mandarim-de-Lacerda; Mônica Manela-Azulay
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.